Variable intensity laser treatments of the skin

Patent No. US9333371 (titled "Variable intensity laser treatments of the skin") on Oct 29, 2013. The application was issued on May 10, 2016.

What is this patent about?

’371 is related to the field of non-ablative dermatological laser treatments. Specifically, it addresses the challenge of heating the dermal layers of the skin to a therapeutic level—sufficient to trigger collagen remodeling and heat-shock protein release—without exceeding the pain threshold or causing epidermal damage. The invention provides a mechanism for achieving a precise thermal plateau rather than a simple peak-and-decay profile.

The underlying idea behind ’371 is that the most effective way to stimulate skin rejuvenation without pain is to rapidly reach a target temperature window and then hold it there using a non-linear energy delivery strategy. By dynamically adjusting the optical fluence during a single, short treatment cycle, the system can overcome the natural thermal diffusion of tissue. This prevents the common problem where a constant stream of energy either takes too long to reach therapeutic levels or overshoots into temperatures that cause burning and discomfort.

The claims of ’371 focus on a handheld, self-contained laser system that utilizes specific wavelengths between 1380 nm and 1570 nm to target depths of 100 to 800 microns. The independent claims specifically protect the method of varying pulsed beam parameters—such as intensity, pulse width, or inter-pulse delay—within a brief 0.2 to 1.5 second window. This modulation is designed to maintain a dermal temperature strictly between 39 and 45 degrees Celsius while delivering a total energy density of 1.5 to 5.0 Joules per square centimeter.

In practice, the invention operates by delivering energy in distinct stages. An initial high-energy burst quickly drives the tissue to the desired temperature. The controller then shifts to a lower-energy phase to allow for thermal diffusion and prevent overshooting the pain threshold, followed by a maintenance phase that provides just enough energy to keep the temperature stable. This is achieved by shortening pulse widths, increasing the time between pulses, or stepping down the laser current as the treatment progresses.

This approach differs from prior solutions that typically use uniform pulse trains, which result in a linear temperature rise followed by a rapid drop-off. By employing a multi-group pulse strategy, the invention maximizes the time the tissue spends in the therapeutic zone. Furthermore, the integration of safety sensors ensures that the laser only fires when in full contact with the skin, preventing light leakage and ensuring the energy is delivered precisely to the targeted dermal locus.

How does this patent fit in bigger picture?

Technical Landscape

In the early 2010s when ’371 was filed, dermatological energy delivery systems were typically implemented using static control interfaces where operational parameters were manually fixed prior to the initiation of a procedure. At a time when systems commonly relied on pre-set values for optical power, pulse width, and frequency to deliver a consistent energy stream, hardware and software constraints made the real-time modulation of energy delivery based on dynamic feedback or variable treatment cycles non-trivial. Consequently, standard engineering practices focused on maintaining high-intensity output through fixed current settings for laser diodes or light-emitting diodes, rather than adaptive control architectures.

Prosecution Position

The disclosed invention represents a technical advancement by transitioning from static energy delivery to a more granular control architecture that manages the interplay between optical power, pulse duration, and duty cycles. This architectural shift addresses the technical problem of localized tissue damage by enabling precise manipulation of energy intensity and thermal relaxation intervals through interchangeable control variables. The integration of these parameters allows for a more sophisticated treatment cycle that can be optimized for specific dermal responses, overcoming the limitations of traditional systems that were restricted to uniform pulse sequences.

Claims

The patent contains a total of 14 claims, with claims 1, 12, and 14 serving as the independent claims. These independent claims focus on a handheld, self-contained laser system and associated methods for localized skin treatment that utilize specific wavelengths and pulsed beam parameters to maintain target tissue temperatures between 39 and 45 degrees Celsius. The dependent claims serve to further define the operational characteristics of the system, including specific pulse grouping sequences, variations in pulse width and intervals, safety sensor integration, and data communication capabilities for software updates and charging.

Key Claim Terms New

Definitions of key terms used in the patent claims.

Term (Source)Support for SpecificationInterpretation
Desired heating temperature range
(Claim 1, Claim 12, Claim 14)
The skin is heated so that a temperature of each target spot rises to a desired temperature range of greater than 39 degrees Celsius and less than 45 degrees Celsius. The controller is configured to drive the laser engine to generate light to maintain a temperature in the target spots within this range. The parameters are changed so as to maintain the desired temperature range in the skin as the heating progresses.A specific thermal window greater than 39 degrees Celsius and less than 45 degrees Celsius maintained in the target skin spots to achieve a therapeutic effect without excessive damage.
Handheld self-contained system
(Claim 1, Claim 12, Claim 14)
The laser source is located within a handheld self-contained system such that the skin is heated. The system includes a laser engine and a controller configured to drive the laser engine to generate light. The handheld system maintains the temperature in the target spots within the desired heating temperature range.A portable laser treatment device that houses the laser source and control components within a single unit capable of being held in a hand during operation.
High fluence into the skin followed by a lower fluence
(Claim 12)
The controller is configured to drive the laser engine at a high fluence into the skin followed by a lower fluence within the treatment time. This is achieved by controlling, in pulses, at least one pulsed beam parameter. The change in parameters during the application of optical energy facilitates maintaining the temperature within the desired range.A sequence of energy delivery where an initial high energy density is applied to rapidly increase temperature, followed by a reduced energy density to stabilize the temperature.
Pulsed beam parameter
(Claim 1, Claim 12, Claim 14)
The attributes of optical power, pulse width (also referred to as pulse duration), time delay between pulses, and total number of pulses dictate the total time and total energy during a treatment cycle. Optical power (also expressed as energy intensity) is typically varied by setting the current that flows through the light emitting element. These combinations of terms may be interchangeable as it relates to the methods of treatment.Variable characteristics of the laser output, specifically pulse energy intensity, pulse width, or time delay between pulses, which are adjusted to control thermal deposition.
Safety sensor
(Claim 14)
A safety sensor near an aperture detects a contact or near-contact with the skin. The system emits energy only while the safety sensor continues to detect contact or near-contact with the skin. This ensures the localized heating of target spots occurs only when the handheld system is properly positioned.A hardware component located near the device aperture that monitors for physical proximity or contact with the skin to gate the emission of laser energy.

Litigation Cases New

US Latest litigation cases involving this patent.

Case NumberFiling DateTitle
3:25-cv-01074Sep 12, 2025Hyper Ice, Inc. v. Namirsa, Inc.

Patent Family

Patent Family

File Wrapper

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents

US9333371

Application Number
US14065640A
Filing Date
Oct 29, 2013
Publication Date
May 10, 2016
External Links
Slate, USPTO , Google Patents